Development and validation of a score to predict mortality in ICU patients with sepsis: a multicenter retrospective study

Background Early and accurate identification of septic patients at high risk for ICU mortality can help clinicians make optimal clinical decisions and improve the patients' outcomes. This study aimed to develop and validate (internally and externally) a mortality prediction score for sepsis fol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of translational medicine 2021-07, Vol.19 (1), p.1-322, Article 322
Hauptverfasser: Weng, Jie, Hou, Ruonan, Zhou, Xiaoming, Xu, Zhe, Zhou, Zhiliang, Wang, Peng, Wang, Liang, Chen, Chan, Wu, Jinyu, Wang, Zhiyi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Early and accurate identification of septic patients at high risk for ICU mortality can help clinicians make optimal clinical decisions and improve the patients' outcomes. This study aimed to develop and validate (internally and externally) a mortality prediction score for sepsis following admission in the ICU. Methods We extracted data retrospectively regarding adult septic patients from one teaching hospital in Wenzhou, China and a large multi-center critical care database from the USA. Demographic data, vital signs, laboratory values, comorbidities, and clinical outcomes were collected. The primary outcome was ICU mortality. Through multivariable logistic regression, a mortality prediction score for sepsis was developed and validated. Results Four thousand two hundred and thirty six patients in the development cohort and 8359 patients in three validation cohorts. The Prediction of Sepsis Mortality in ICU (POSMI) score included age [greater than or equai to] 50 years, temperature < 37 [degrees]C, Respiratory rate > 35 breaths/min, MAP [less than or equai to] 50 mmHg, SpO2 < 90%, albumin [less than or equai to] 2 g/dL, bilirubin [greater than or equai to] 0.8 mg/dL, lactate [greater than or equai to] 4.2 mmol/L, BUN [greater than or equai to] 21 mg/dL, mechanical ventilation, hepatic failure and metastatic cancer. In addition, the area under the receiver operating characteristic curve (AUC) for the development cohort was 0.831 (95% CI, 0.813-0.850) while the AUCs ranged from 0.798 to 0.829 in the three validation cohorts. Moreover, the POSMI score had a higher AUC than both the SOFA and APACHE IV scores. Notably, the Hosmer-Lemeshow (H-L) goodness-of-fit test results and calibration curves suggested good calibration in the development and validation cohorts. Additionally, the POSMI score still exhibited excellent discrimination and calibration following sensitivity analysis. With regard to clinical usefulness, the decision curve analysis (DCA) of POSMI showed a higher net benefit than SOFA and APACHE IV in the development cohort. Conclusion POSMI was validated to be an effective tool for predicting mortality in ICU patients with sepsis. Keywords: Sepsis, Intensive care unit, Mortality prediction score
ISSN:1479-5876
1479-5876
DOI:10.1186/s12967-021-03005-y